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Abstract 
With the use of genetic technology, researchers have the potential to inform medical 
diagnoses and treatment in actionable ways. Accurate variant interpretation is a necessary 
condition for the utility of genetic technology to unfold. This relies on the ability to access 
large genomic datasets so that comparisons can be made between variants of interest. This 
can only be successful if DNA and medical data are donated by large numbers of people to 
‘research’, including clinical, non-profit and for-profit research initiatives, in order to be 
accessed by scientists and clinicians worldwide.  
 
The objective of the ‘Your DNA, Your Say’ global survey is to explore public attitudes, values 
and opinions towards willingness to donate and concerns regarding the donation of one’s 
personal data for use by others. Using a representative sample of 8,967 English-speaking 
publics from the UK, the USA, Canada and Australia, we explore the characteristics of 
people who are unwilling (n=1,426) to donate their DNA and medical information, together 
with an exploration of their reasons. Understanding this perspective is important for making 
sense of the interaction between science and society. It also helps to focus engagement 
initiatives on the issues of concern to some publics.  
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1 Introduction 
 
1.1 Large genomic datasets underpin genomic medicine 
In order to fully realise the potential of genomic medicine to predict, diagnose, manage and 
treat genetic disease, clinical scientists routinely access de-identified genomic datasets 
containing DNA and medical information from large numbers of people. Projects such as the 
Million European Genomes Alliance plan to link electronic patient records with genomic 
sequencing results from 1 million people across Europe in order to meet this need for very 
large datasets with both genotype and phenotype information (European Commission. 
2018).  
 
There has been wide support (Boycott et al. 2017; Budin-Ljosne et al. 2014) for genomic 
data sharing, together with a call for practical and ethical solutions to connect genomic 
databases and make them more accessible for clinical and research purposes (Thompson et 
al. 2014). Such health-related data are sensitive and may be potentially misused (e.g. 
discrimination) or used in ways not supported by the data contributors (Sterckx et al. 2016). 
Consequently, scholars have called for consistent ethical and legal frameworks that enable 
access across institutional and national jurisdictions that respect and protect individuals who 
have contributed data (Knoppers et al. 2014; Borry et al. 2018). Such regulatory frameworks 
in turn aim to meet the needs of people who currently refuse to participate in genetic 
research out of fear for genetic discrimination (Wauters and Van Hoyweghen 2016). 
 
To determine whether a variant is consistently linked to a particular phenotype, datasets 
should ideally contain information from people of varying ages, disease status, health and 
ethnicity. However, many existing genomic databases have limitations in terms of the 
population they represent, with the vast majority of studies focussed primarily on European 
populations (Popejoy and Fullerton 2016; Landry et al. 2018). In order to meet the demand 
for larger numbers and more diversity, millions of people globally will need to donate and 
share their data (Middleton 2018; Birney, Vamathevan, and Goodhand 2017). There have 
thus been calls to encourage the donation of data which includes a broader population as 
well as disease status, in order to support the equitable delivery of genomic medicine 
(Sirisena and Dissanayake 2017).  
 
In this manuscript, we use the term ‘data donation’ to refer to the decision an individual 
makes to contribute their genomic data to a database that can be accessed by researchers 
or clinicians. The act of ‘data donation’ assumes that these data will be subsequently 
accessed by and shared with others for clinical and research purposes. Opportunities to 
donate DNA and/or medical data arise when individuals undergo genetic testing (Wright CF 
2017), store samples in biobanks (Small, O'Donnell, and Damrauer 2018), participate in 
clinical research (Auffray et al. 2016) or when they donate their blood to blood banks 
(Hartling et al. 2015). Understanding what motivates and de-motivates data donation is 
pivotal to creating appropriately designed engagement, dialogue strategies and regulatory 
frameworks about genomic medicine and research.  
 
1.2 Attitudes towards data donation 
Empirical research on public attitudes to data sharing tells us that, broadly speaking, publics 
are willing to donate and share their health data with researchers (Weitzman et al. 2012; 
Health Research Authority and Human Tissue Authority. 2018). One driver of this is the 
perceived use of data and expectations of data users, as many participants see their 
contribution to research as helping towards the ‘public good’ (Dixon-Woods and Tarrant 
2009). In contrast, participants’ view of data donation becomes less positive  when they are 
not consulted on the uses of their data (McCormack et al. 2016) or believe that their 
donation will primarily lead to big profits for commercial companies, without creating obvious 
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public value (Trinidad et al. 2010) . Research from Wellcome has shown participation in 
research and data sharing are viewed as more acceptable when care and attention is paid to 
explaining the necessary partnerships between industry and healthcare (Wellcome Trust. 
2016).  In addition, previous survey research, primarily in the USA, has suggested that there 
may be important differences in the characteristics of those willing to donate their genomic 
data to research, particularly associated with education, race, religiosity and levels of 
perceived benefit and concern (Sanderson et al. 2017; Shabani, Bezuidenhout, and Borry 
2014). 
 
In this paper, we focus on the characteristics and reasoning of people who are unwilling to 
donate their DNA and medical data to research using findings from the ‘Your DNA, Your 
Say’ international survey.  The ‘Your DNA, Your Say’ survey is part of a global project that 
has been translated into several languages, including: Russian, Polish, Portuguese, 
Spanish, German, Icelandic, Swedish, French, Japanese, Urdu, Arabic, and Italian with 
plans to translate into Hindi, Mandarin, Zulu, Twi and Ewe. Once global recruitment is 
completed, we will perform a between-country meta-analysis of attitudes, which will be 
described separately. Here we present here data from the English-speaking participants (for 
whom recruitment has finished). The survey was developed in collaboration with the 
Participant Values task team of the Global Alliance for Genomics and Health, a public-
private consortium developing policy frames and technical standards for the exchange of 
genomic and health-related data. 
 
2 Methods 
A more detailed description of the methodological rationale for the study, design (and 
limitations), recruitment strategy, and process of data collection have been published 
separately (Middleton et al. 2018), as has a review of the context and background to this 
project (Middleton 2018).  
 
2.1 Sample 
Using a market research company, ResearchNow, we collected completed surveys from 
publics in the USA, Canada, United Kingdom (UK) and Australia (n = 8,967). Participants 
were paid a small financial reward (<£1) for participating and due to the nature of recruitment 
there are no details on non-response rate. Our participant samples are ‘representative’, 
according to recent census data, of populations in Canada, the USA, the UK and Australia in 
terms of age and gender. However, as we did not specifically aim to recruit a ‘representative’ 
sample according to self-reported ethnicity, the ethnic diversity of our sample cannot be 
considered ‘ethnically representative’. We found only small variation in between-country 
analysis and have corrected for this in the modelling; thus, in this paper we have chosen not 
to focus specifically on differences between participant attitudes from the UK, the USA, 
Canada, and Australia but to explore the collective profiles of those participants, across 
countries.  
 
2.2 Measures 
Our cross-sectional, exploratory online survey can be accessed from 
www.YourDNAYourSay.org. It contains 29 questions and piloting showed it took 
approximately 15-20 minutes to complete.  
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Donating DNA and medical information 
Throughout the survey, participants were asked whether they would donate their 
“anonymous''1 DNA and medical information for use by others in research. We asked 
participants to distinguish who they would allow to use their data, (a) medical doctors; (b) 
non-profit researchers; (c) for-profit researchers. Participants were classified as willing to 
donate if they answered “yes” to at least one of these questions, unwilling to donate if they 
answered “no” to all three, and unsure if they answered “unsure” to all three. We will publish 
separately on the profile of those who were more accepting of data donation (Middleton et 
al, under review) and on the distinctions participants make between users of their data. 
 
Sociodemographics 
Age was collected in ten-year categories from age 16 onwards, but due to the lower number 
of responses in younger and older age categories these were collapsed into three categories 
of “30 years and under”, “31-50”, and “51 years and older'' for analysis. Whether participants 
had children was determined by a “Yes'' or “No'' answer without specifying whether the 
children were biological or not. Relationship status was collected as “Divorced'', “Separated'', 
“Single'', “Widowed'', “Married / civil partnership / living together'', but all categories apart 
from the latter were collapsed for analyses. 
 
We piloted how best to collect ethnicity data, starting with the categories provided in the UK 
Census survey and adapting these, based on feedback from pilot participants involved in 
survey development. The resultant ethnicity question in the final survey thus asked 
participants to self-identify as (1) White, (2) Afro-European/African American, Black (3) 
Hispanic (4) South Asian, Indian, Pakistani (5) East Asian Chinese, Japanese (6) Arabic, 
Central Asian (7) Other (Table 1). Participants could also choose not to answer this question 
at all. In the analysis, due to the low number of participants who self-identified as a member 
of a group other than “White” (less than 10% of the sample for each country), these were 
collapsed into a single “Non-White” category for analysis. Highest level of education was 
categorised as “Tertiary'', “Secondary'', “Primary'' or “Other'' based on structured responses 
and also free-text descriptions of educational qualifications. This was collapsed to a binary 
indicator of tertiary education for multivariable analyses. Religiosity was determined by 
participant response to the question “Independent of whether you attend religious services 
or not, would you say you are…?'' with options “A religious person'' or “Not a religious 
person''. 
 
Genetics experience 
Genetics experience was derived from two variables: “Are you familiar with DNA, genetics, 
or genomics?'' If a respondent chose the answer: “I’m familiar through my work, personal 
interests or family/medical history'', they could further specify. Participants were categorised 
as having “Personal'' experience of genetics if they said they were familiar with 
DNA/genetics/genomics and that familiarity was due to either having a genetic condition in 
their family, or through their work (e.g. genetic health professional or genetic researcher). 
                                                 
1
 Within the survey glossary we explained ‘anonymous’ in more detail: ‘Anonymous: removal of personal 
information such as name and date of birth. It is questionable as to whether DNA information can ever be truly 
anonymous as our DNA code is unique to us and thus, in itself, could be used to identify us. However, in the 
circumstances we are exploring here, by making DNA and medical information 'anonymous', we mean 
detaching personal identifiers from it.’ What we are actually meaning here is ‘de-identified’ but within the 
pilot work for the survey we discovered that public participants did not naturally understand this term and 
‘anonymous’ was more easily understood, thus we added the glossary definition within the survey itself, to 
explain this in more detail. 
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Participants without this experience were categorised as “Familiar'' or “Unfamiliar'' based on 
their response to the first question. 
 
Potential for harm 
Participants were asked a single question regarding harms associated with linking 
personally identifying information to their DNA data: “If someone linked your name, address 
and phone number to it, do you think you could be harmed in any way from this?'' Response 
options were ”Yes'', “No'', “I'm not sure'' with the latter two categories collapsed for analysis.   
 
Concerns about specific harms 
Participants were presented with a list of hypothetical harms that could occur in relation to 
DNA information and asked to indicate which three of these concerned them the most. The 
list of hypothetical harms was based on pilot work, the academic literature and experience of 
the authors who designed the survey. The list of hypothetical harms presented to 
participants was: 
 
• My friends potentially knowing something about me that I hadn't chosen to tell them 
• My family potentially knowing something about me that I hadn't chosen to tell them 
• My government potentially knowing something about me that I hadn't chosen to tell 
them 
• Police potentially knowing something about me that I hadn't chosen to tell them 
• Marketing companies targeting me to sell me products 
• Being stigmatised and labelled in some way online 
• Being cloned 
• My DNA being copied and then planted at the scene of a crime 
• Health or life insurance companies using the information to discriminate against me 
• Employers using the information to discriminate against me 
• Upsetting my genetic relatives 
• Ethnic identification and racial discrimination 
 
Factors affecting the decision to donate 
Participants were asked to identify what factors would influence their decision to donate their 
DNA and medical information. They were asked to select from the following list (multiple 
selections possible): 
 
• Whether my identifying information (age, sex, etc.) will be included or not 
• Who has control over access to my information 
• What sorts of research my information could be used in 
• The potential risks and benefits of making a donation 
• How the researcher might benefit from accessing my information 
• What sort of researchers are likely to access my information 
• How I might be acknowledged for my contribution to scientific knowledge 
• If the researchers were going to make money with the results 
• Whether I would have access to the DNA readout generated by researchers 
• If I can participate in the governance of data access 
• How I will be assisted if there is a data breach 
 
2.3 Statistical analysis 
Sample characteristics were summarised using standard descriptive statistics, and bivariate 
relationships were evaluated using ??2 tests as all variables were categorical. Importance of 
p-values was considered in the context of multiple testing. The multivariable analysis of 
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participant characteristics associated with donation preference was conducted using a 
multinomial logistic regression model with donation preference as the outcome variable. A 
complete-case sample was used. We have previously used multi-level models to analyse 
these data (Middleton et al, under review) but comparison of model fit showed that a multi-
level model was not necessary for donation preference. Familiarity with genetics, age, 
gender, ethnicity, country of residence, marital status, having children, education level, and 
religiosity were included as covariates. As this model was explanatory rather than predictive, 
no variable selection methods were used and the full model is presented. 
 
3 Results 
3.1 Attitudes towards donation 
In this sample, 15.9% of participants (n = 1,426) reported that they were unwilling to donate 
their DNA and medical information to medical doctors, non-profit researchers, or for-profit 
researchers (with the explained assumption that these professionals would then access and 
share this data with others in their specific field).  A further 16.3% (n = 1,462) were unsure in 
all cases.  The majority (67.7%; n = 6073) were willing to donate in at least one scenario 
(this latter group are explored in more depth elsewhere, Middleton et al, under review). Data 
on this topic were missing for 6 participants, who were excluded from further analyses.  
 
Insert Table 1 here 
 
Table 1: Sample description (n = 8,961).  Participants willing, unwilling and unsure about 
donating DNA and/or medical information to research (including to medical doctors, non-
profit and for-profit researchers) associated with familiarity about genetics and demographic 
variables.  
P-values for χ2 tests (excluding missing data) are shown 
 
Compared to those who were willing to donate (Table 2), those who were unsure or unwilling 
had substantially lower odds of being familiar with, or having a personal experience of, 
genetics/genomics. Both of these groups also had lower odds of being aged 30 and under, 
and higher odds of not having a tertiary-level qualification and of self-identifying as a 
member of an ethnic group other than White.   
 
Insert Table 2 here 
 
Table 2: Multinomial logistic regression result for views on donation, with willing to donate as 
reference category (n = 8,703), associated with familiarity about genetics and demographic 
data.   
OR indicates odds ratio; LCI indicates lower 95% confidence interval; UCI indicates upper 95% 
confidence interval. 
 
 
Table 2 also shows people who were unwilling to donate had a different sociodemographic 
profile than those who were unsure. Specifically, those unwilling and unsure about donating 
differed in relation to gender, having children, country of residence, and religiosity. 
Compared to those who were willing to donate, those who were unsure had much lower 
odds of being male (odds ratio (OR) 0.74; 95% confidence interval (CI) 0.66-0.84; p < 
0.0001) whereas there was no gender difference between those who were and were not 
willing to donate. There was no difference between those people who were willing to donate 
and those who were unsure in terms of having children or country of residence, but these 
factors were strongly associated with being unwilling to donate; unwilling participants had 
much lower odds of having children (OR 0.74; 95%CI 0.65-0.84; p < 0.0001), and greater 
odds of residing in the USA or Australia (OR 1.37; 95%CI 1.15-1.62; p < 0.0001 and OR 
1.28; 95%CI 1.07-1.53; p = 0.008 respectively). Those unsure about donating had lower 
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odds of being religious (OR 0.78; 95%CI 0.69-0.90; p = 0.003), but there was no substantial 
difference between those who were and were not willing to donate in terms of religiosity. Put 
simply, those who were unsure about data donation were more likely to be female, to have 
children, and to reside in the USA or Australia, but less likely to be religious than those who 
were unwilling to donate data (both compared to those willing to donate their data). 
 
3.2 Perceptions of harms arising from linking personal and DNA/medical information 
A similar percentage of participants in the willing and unwilling to donate groups (45.1% and 
45.6% respectively) believed that linking their DNA and medical information to their personal 
details could result in personal harm, whereas only 27.8% of unsure participants agreed with 
the statement (Table 3). This reflects the fact that those participants who were unsure 
overall were also more likely to be unsure about the potential for data linkage to result in 
harm, and thus less likely to agree with the statement. 
 
 
Insert Table 3 here 
 
Table 3: Numbers and percentages of participants in each donation group endorsing 
individual potential harms.   
P-values for χ2 tests are shown. 
 
 
Insert Figure 1 here 
 
Figure 1: Hypothetical harms arising from linking personally identifiable information (name, 
address etc) to DNA information. Participants were asked to rate if they were concerned 
about these and then stratified according to willingness to donate DNA and/or medical data 
to research (including clinical, non-profit, for-profit research) 
 
The potential harm identified most frequently by participants was “My DNA being copied and 
then planted at the scene of a crime”; 45% of each group endorsed this (see Table 3; Figure 
1). The three groups were also similar in terms of concern regarding family and friends 
knowing something about them, and employers using the information to discriminate against 
them. However, the three groups differed in relation to other concerns about potential harms. 
The other harms most frequently endorsed by the willing-to-donate group were: “Health or 
life insurance companies using the information to discriminate against me” (39.2%) and 
“Marketing companies targeting me to sell products” (36.7%).   
 
The unwilling-to-donate group were also concerned about insurance discrimination (33.7%), 
and marketing uses of data (30.7%). However, they were more concerned about “My 
government potentially knowing something about me that I hadn’t chosen to tell them” 
(40.3%). This was a higher percentage than those in the willing-to-donate and unsure 
groups (30.5% and 31.1% respectively; ??2=51.08; df=2; p < 0.0001). This group was also 
more likely to be concerned about “Police potentially knowing something about me that I 
hadn’t chosen to tell them” (23.8% compared to 17% of the other groups; ??2=35.53; df=2; p 
< 0.0001). 
 
3.3 Factors influencing the decision to donate DNA/medical information 
There were substantial differences between the three donation groups for all the factors 
influencing donation that participants were asked to explore (see Table 4; Figure 2). 
However, the differences all followed the same pattern: participants who were unwilling to 
donate were proportionally less likely to identify a factor as influencing their decision to 
donate than those who were willing to donate. 
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The factor that unwilling-to-donate participants most commonly identified as influencing their 
decision to donate was the question of who would control access to their information (27%), 
followed by whether identifying information would be included or not (24%). Participants 
were least likely to be influenced in their decision by whether they would be acknowledged 
for their contribution (10%) and whether they would be able participate in the governance of 
data access (11%). 
 
Insert Table 4 here 
 
Table 4: Numbers and percentages of participants in each donation group endorsing 
particular considerations regarding donation.   
P-values for χ2 tests are shown. 
 
Insert Figure 2 here 
 
Figure 2: Considerations that might affect willingness to donate DNA and/or medical 
information, stratified by reported willingness to donate. 
 
4 Discussion 
 
The focus of this paper is on the profile and characteristics of those participants who said 
they were unwilling to donate their DNA and medical data to be shared in clinical and 
scientific research. Our results show those members of the public who said they were 
unwilling to donate their DNA and medical data had a broad demographic profile. They were 
more likely to be older (men or women), without children, with lower levels of education, to 
be from the USA or Australia and to have self-reported ethnicity as any of the groups other 
than White. Along with those who were ‘unsure about donation’, those who were unwilling to 
donate were a group with little reported familiarity with DNA, genetics and genomics. The 
key question arising from the results is why this particular profile might be associated with 
being unwilling to donate one’s data. 
 
A first explanation would be that this group are more concerned than others about the 
overall harms associated with re-identification. Our data suggests this is not the case. The 
proportion who thought it was possible that they could be harmed was not greater amongst 
participants unwilling to donate than among those who were willing. Importantly, however, 
the types of concerns were different amongst this group. Specifically, in comparison with 
those who were willing to donate, the unwilling group were more likely to say that they were 
worried about the government or police knowing something about them that they had not 
chosen to share. They were less likely to identify harms associated with insurance and 
marketing uses of data.  
 
These data suggest that increasing familiarity with DNA, genetics and genomics may not be 
enough to convert someone who is unwilling about donation to someone more willing to 
donate. Familiarity is a key difference between the otherwise similar profiles (in terms of all 
variables we measured) of those who are ‘unsure about donation’ and those who are willing 
to donate. Consequently, increasing familiarity may result in the current ‘unsures’ potentially 
converting to a ‘yes’ to donation. However, we are less confident about this prediction for 
those currently ‘unwilling to donate’. This group differ across variables from those who are 
willing to donate, both in terms of the potential harms they perceive and the factors which 
influence their decision to donate. Rather than familiarity, a key feature of this group appears 
to be unease with systems of legal and political authority, notably governments and the 
police. This may explain the lack of success of legal controls in limiting concerns about 
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genetic discrimination (Wauters and Van Hoyweghen 2016) and suggests the potential 
limitations of approaches to dialogue which do not take such concerns into account.  
 
Whilst our research study did not set out to explore attitudes specifically from particular 
ethnic groups (although between-country attitudes will be explored) we have found that 
those who self-identify as a member of an ethnic group other than White have higher odds of 
being unwilling to donate their DNA or health data. The combination of concerns about 
government and police use of data with potential ethnic differences in the data echoes 
previous research which has reported concern that genetic results could be used to racially 
discriminate (Goldenberg et al. 2011). We all have, irrespective of our ethnic or racial 
background, a right to protection against discrimination. However, fear of discrimination is 
very significant for some (Wauters and Van Hoyweghen 2016). Ethnic minority groups 
including African American/European Black and Asian groups have at times been reported 
to have a difficult relationship with genomics services (Mathew et al. 2017), the reasons for 
which are complex. Within the context of data donation for the assessment of disease risk 
(such as cancer) the perception of stigma (the notion of being at risk) and taboo could 
contribute to unwillingness to donate among ethnic minority groups along with low level of 
knowledge and awareness of familial cancer risk (Hann et al. 2017; Allford et al. 2014). Also, 
the aniticipated impact on minority communities could explain reluctance to donate; such as 
the stratification of society into people with “good” and “bad” genes leading to genomic 
medicine largely benefiting a privileged few (Bentley et al. 2017).This literature emphasises 
the importance of previous ethical injustices within medical research (Underwood et al. 
2013) and fears of discrimination (Buseh et al. 2013) which provide potential causes for 
mistrust (Buseh et al. 2014) and fear (Catz et al. 2005). Steps should be taken to 
acknowledge and address these very real fears so as not to perpetuate perceptions of 
discrimination and persecution; policy makers have begun to explore practical steps to do 
this, including advocating the need for cultural literacy amongst geneticists, and promotion of 
evidence based ethical engagement strategies (Claw et al. 2018; Staunton et al. 2018). 
 
Before deciding whether to offer one’s DNA and medical data to be used in research, 
individuals would benefit from access to clear information about the risks and benefits, as 
well as details of the types of research for which the data will be used. Research and clinical 
programmes need to be more transparent about how they collect, store, process, and share 
data, as well as how they safeguard data against potential breaches and how such breaches 
will be dealt with if they occur.  However, the practice of responsible genomic research also 
needs be accompanied by a public dialogue about the implications of genomic testing and 
the use of results. Even if we are not personally undergoing genetic testing, it is increasingly 
possible that a biological relative is, whether for clinical or research purposes or personal 
interest. The decisions that our relatives make about whether to donate their DNA and 
medical data for research are also relevant to us. Given that all of us are likely to be 
confronted with the outcomes from genomic testing within our lifetimes, whether we interact 
with it as citizens, patients or consumers (Roberts and Middleton 2018) it is time that the 
issues linked to genomic medicine are mainstreamed conversationally, or ‘socialised’ (Parry 
and Middleton 2017).  
 
With more efforts to familiarise publics with genomics, and greater public dialogue about the 
pertinent issues, risks, and benefits of data donation and sharing, it is possible that those 
members of the publics who are currently unsure about whether to donate, may make an 
informed decision to participate. Equally, such dialogue should aim to engage those who are 
currently unwilling to take part in genomic research, perhaps through discussion of the 
principles and protections which govern data use. Benefiting from the advances in science is 
a fundamental human right that all of us have, irrespective of our ethnicity (Knoppers et al. 
2014), and future public engagement approaches should consider how to engage with the 
mistrust reported by certain publics, particularly those who do not self-identify as White.  
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The size of the sample analysed for this paper does not give us the power to differentiate 
attitudes between the ethnic groups that are not self-identified ethnically as White. As such, 
we have deliberately kept our analysis broad. However, we believe that nuances in attitude 
relevant to ethnicity would benefit from more research, perhaps using a more subtle 
approach than an online survey can deliver. While this survey has identified potential areas 
of concern, it is not possible to draw out in greater detail the magnitude of the concerns 
identified; this would be an important focus of future work. Finally, online surveys have some 
important limitations, which we have discussed in detail in the methods paper that 
accompanies our work (Middleton et al. 2018). To understand in detail the reasons why 
different groups of people are more or less willing to donate or more or less trusting of 
different research/clinical programmes, there would be value in complementing the current 
work with a deep qualitative approach.  
 
5 Conclusion 
To deliver genomic medicine at scale across the world, large datasets containing genomic 
and phenotypic data are required from millions of people. These datasets are pivotal in 
variant interpretation to determine whether a result in an individual has been seen frequently 
in population studies before and whether it is known to be linked to disease. These datasets 
have traditionally been collected by researchers, scientists and clinicians over the years as 
genomics has evolved. Yet, fundamentally they rely on people agreeing to donate their data 
to be used in this way.  
 
The ‘Your DNA Your Say’ survey explores attitudes towards the donation of one’s own de-
identified personal DNA and medical information to be accessed and shared for research.   
In this paper we have reported the profile of public participants from the UK, the USA, 
Canada and Australia, who say they are unwilling to donate their DNA and medical data. 
The ‘unwilling’ were more likely to be older, of lower education background, childless, be 
from the USA or Australia and to identify themselves as an ethnic minority group that is not 
White. They were also more likely to express concerns that were different to those who were 
more enthusiastic about data donation, more specifically, they were worried about 
governments and police knowing information that they had not chosen to share. These 
findings may reflect persistent concerns about discrimination and persecution. In the future 
ethical and evidence-based public engagement strategies should consider how to 
acknowledge and engage with these fears and the cultural and political concerns which 
accompany potential involvement in genomic research.  
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Table 1: Sample description (n = 8,961).  Participants willing, unwilling and unsure about donating DNA and/or medical information to research 
(including to medical doctors, non-profit and for-profit researchers) associated with familiarity about genetics and demographic variables. P-
values for χ2 tests (excluding missing data) are shown. 
 
Variable Categories 
Total 
(n = 8,961)   
Willing  
(n = 6,073)   
Unwilling 
(n = 1,426)   
Unsure 
(n = 1,462) P 
    N %   N %   N %   N %   
Genetics 
knowledge 
Unfamiliar 
5004 55.8 3036 50 918 64.4 1050 71.8 
<0.0001 
 
 Familiar 2786 31.1 2052 33.8 407 28.5 327 22.4 
 Personal 1170 13.1 985 16.2 100 7 85 5.8 
 Missing 1 0 0 0 1 0.1 0 0 
Age 30 and under 
2090 23.3 1493 24.6 270 18.9 327 22.4 
<0.0001 
 
 31-40 2046 22.8 1406 23.2 310 21.7 330 22.6 
 41-50 1569 17.5 988 16.3 272 19.1 309 21.1 
 51-60 1588 17.7 1011 16.6 297 20.8 280 19.2 
 Over 60 1664 18.6 1172 19.3 277 19.4 215 14.7 
 Missing 4 0 3 0 0 0 1 0.1 
Gender Female 
4328 48.3 2895 47.7 631 44.2 802 54.9 
<0.0001 
 
 Male 4573 51 3154 51.9 780 54.7 639 43.7 
 Missing 60 0.7 24 0.4 15 1.1 21 1.4 
Children No 3695 41.2 2445 40.3 641 45 609 41.7 0.001 
 Yes 5111 57 3556 58.6 743 52.1 812 55.5 
 Missing 155 1.7 72 1.2 42 2.9 41 2.8 
Education Tertiary 
5172 57.7 3664 60.3 759 53.2 749 51.2 
<0.0001 
 
 Secondary 3009 33.6 1943 32 520 36.5 546 37.3 
 Primary 551 6.1 331 5.5 103 7.2 117 8 
 Other 224 2.5 131 2.2 44 3.1 49 3.4 
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Variable Categories 
Total 
(n = 8,961)   
Willing  
(n = 6,073)   
Unwilling 
(n = 1,426)   
Unsure 
(n = 1,462) P 
    N %   N %   N %   N %   
 Missing 5 0.1 4 0.1 0 0 1 0.1 
Country United Kingdom 3316 37 2257 37.2 486 34.1 573 39.2 0.006 
 United States 1992 22.2 1366 22.5 334 23.4 292 20 
 Canada 2251 25.1 1544 25.4 349 24.5 358 24.5 
 Australia 1402 15.6 906 14.9 257 18 239 16.3 
Ethnicity Afro-European, African American, 
Black 322 3.6 211 3.5 56 3.9 55 3.8 0.088 
 Asian 660 7.4 422 6.9 117 8.2 121 8.3 
 Hispanic 139 1.6 85 1.4 27 1.9 27 1.8 
 Other 193 2.2 121 2 36 2.5 36 2.5 
 White 7538 84.1 5186 85.4 1150 80.6 1202 82.2 
 Missing 109 1.2 48 0.8 40 2.8 21 1.4 
Religiosity Not a religious person 
5608 62.6 3695 60.8 923 64.7 990 67.7 
<0.0001 
 
 A religious person 3348 37.4 2374 39.1 503 35.3 471 32.2 
 Missing 5 0.1 4 0.1 0 0 1 0.1 
Relationship Married / civil partnership / living 
together 5564 62.1 3847 63.3 829 58.1 888 60.7 0.001 
 Divorced/Single/Widowed 3392 37.9 2222 36.6 597 41.9 573 39.2 
  Missing 5 0.1   4 0.1   0 0   1 0.1   
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Table 2: Multinomial logistic regression result for views on donation, with willing to donate as reference category (n = 8,703), associated with 
familiarity about genetics and demographic data.  OR indicates odds ratio; LCI indicates lower 95% confidence interval; UCI indicates upper 95% confidence 
interval. 
 
Variable Category Unwilling   Unsure 
    OR LCI UCI P   OR LCI UCI P 
Genetics 
knowledge 
Unfamiliar ref.     ref.    
 Familiar 0.66 0.58 0.76 <0.0001  0.5 0.43 0.58 <0.0001 
 Personal 0.35 0.28 0.43 <0.0001  0.25 0.2 0.32 <0.0001 
Age Over 50 ref.     ref.    
 31-50 0.93 0.81 1.07 0.34  1.2 1.04 1.38 0.01 
 30 and under 0.64 0.54 0.77 <0.0001  0.9 0.75 1.07 0.22 
Gender Female ref.     ref.    
 Male 1.12 0.99 1.27 0.06  0.74 0.66 0.84 <0.0001 
Children No ref.     ref.    
 Yes 0.74 0.65 0.84 <0.0001  0.92 0.81 1.05 0.20 
Tertiary 
education 
Yes ref.     ref.    
 No 1.26 1.11 1.43 0.0003  1.31 1.16 1.49 <0.0001 
Country United Kingdom ref.     ref.    
 United States 1.37 1.15 1.62 0.0003  1.08 0.91 1.29 0.36 
 Canada 1.09 0.93 1.28 0.29  1.08 0.92 1.27 0.33 
 Australia 1.28 1.07 1.53 0.008  1.09 0.91 1.3 0.34 
Ethnicity White ref.     ref.    
 Non-White 1.37 1.15 1.62 0.0004  1.35 1.14 1.61 0.0005 
Religious person No ref.     ref.    
  Yes 0.87 0.76 0.99 0.03   0.78 0.69 0.9 0.0003 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 4
 
 
 
 
Table 3: Numbers and percentages of participants in each donation group (i) agreeing that linkage of personal information to DNA could result 
in harm; (ii) endorsing individual potential harms.  P-values for χ2 tests are shown. 
 
Variable Total   Willing   Unwilling   Unsure P 
  N %   N %   N %   N %   
Agreement to “If someone linked your name, address and phone number to [your DNA], do you 
think you could be harmed in any way from this?” 
3816 42.6  2767 45.6  643 45.1  406 27.8 <0.0001 
             
My DNA being copied and then planted at the scene of a crime 4050 45.2  2741 45.1  645 45.2  664 45.4 0.981 
My family potentially knowing something about me that I hadn't chosen to tell them 1871 20.9   1311 21.6   277 19.4   283 19.4 0.057 
My friends potentially knowing something about me that I hadn't chosen to tell them 1981 22.1  1368 22.5  277 19.4  336 23 0.027 
Employers using the information to discriminate against me 2131 23.8  1503 24.7  306 21.5  322 22 0.007 
Health or life insurance companies using the information to discriminate against me 3333 37.2  2379 39.2  480 33.7  474 32.4 <0.0001 
Marketing companies targeting me to sell me products 3139 35 2230 36.7 438 30.7 471 32.2 <0.0001 
My government potentially knowing something about me that I hadn't chosen to tell them 2882 32.2  1853 30.5  574 40.3  455 31.1 <0.0001 
Police potentially knowing something about me that I hadn't chosen to tell them 1630 18.2  1042 17.2  339 23.8  249 17 <0.0001 
Being stigmatised and labelled in some way online 1941 21.7 1362 22.4 257 18 322 22 0.001 
Being cloned 2510 28 1556 25.6 453 31.8 501 34.3 <0.0001 
Upsetting my genetic relatives (because my DNA information is similar to their DNA information) 1306 14.6 809 13.3 218 15.3 279 19.1 <0.0001 
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Table 4: Numbers and percentages of participants in each donation group endorsing particular considerations regarding donation.  P-values for χ2 
tests are shown. 
 
Variable Total   Willing   Unwilling   Unsure P 
  N %   N %   N %   N %   
whether my identifying information 5076 56.6 4053 66.7 336 23.6 687 47 <0.0001 
who has control over access to my information 5333 59.5 4224 69.6 386 27.1 723 49.5 <0.0001 
what sorts of research my information could be used in 4056 45.3 3159 52 303 21.2 594 40.6 <0.0001 
the potential risks and benefits of making a donation 4110 45.9 3234 53.3 293 20.5 583 39.9 <0.0001 
how the researcher might benefit from accessing my 
information 3378 37.7 2656 43.7 262 18.4 460 31.5 <0.0001 
what commercial profits would be made on the basis of my 
information 3289 36.7 2605 42.9 237 16.6 447 30.6 <0.0001 
what sort of researchers are likely to access my information 3497 39 2748 45.2 253 17.7 496 33.9 <0.0001 
how I might be acknowledged for my contribution to 
scientific knowledge 1939 21.6 1494 24.6 143 10 302 20.7 <0.0001 
if the researchers were going to make money with the results 3126 34.9 2477 40.8 213 14.9 436 29.8 <0.0001 
whether I would have access to the DNA readout generated 
by researchers 3381 37.7 2711 44.6 218 15.3 452 30.9 <0.0001 
if I can participate in the governance of data access 2062 23 1600 26.3 160 11.2 302 20.7 <0.0001 
how I will be assisted if there is a data breach 3697 41.3   2951 48.6   240 16.8   506 34.6 <0.0001 
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how the researcher might benefit from accessing my information
what commercial profits would be made on the basis of my information
what sort of researchers are likely to access my information
how I might be acknowledged for my contribution to scientific knowledge
if the researchers were going to make money with the results
whether I would have access to the DNA readout generated by researchers
if I can participate in the governance of data access
how I will be assisted if there is a data breach
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